1-1 of 1
David Zahrieh, M.S.
Close
Sort by
Journal Articles

A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).

Philip C. Amrein, MD, Eyal C. Attar, M.D., Tak Takvorian, M.D., Ephraim P. Hochberg, M.D., Karen Ballen, M.D., David Zahrieh, M.S., Jennifer R. Brown, M.D.
Journal: Blood
Blood (2007) 110 (11): 3126.
https://doi.org/10.1182/blood.V110.11.3126.3126
Published: 2007